Company / Current Assets
Enovis Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.2B
FY2025
5-year range
$795.0M / $2.3B
FY2021-FY2025
Trend
+5.3%
vs FY2024
Sector context
#64 of 160
Health Care
What the data says
At $1.2B, Enovis's current assets ranks #64 of 160 in the Health Care sector. Current Assets has increased for 3 consecutive years, from $795M in FY2022 to $1.2B in FY2025.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of -2.4%.
Improved from $897M to $1.2B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +14.9%
- 5-Year CAGR
- -2.4%
- 10-Year CAGR
- -
Sector benchmark
#64 of 160 in Health CareTop 40% of 160This company $1.2B Sector average $5.2B
▼
-76.9% below sector average
Key checks
Key Insights
- Enovis's current assets has grown for 3 consecutive years.
- 5-year CAGR of -2.4%, indicating a declining trend.
- In FY2025, current assets increased 5.3% year-over-year.
- Ranks #64 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +5.3% |
| FY2024 | $1.1B | +27.9% |
| FY2023 | $896.5M | +12.8% |
| FY2022 | $795.0M | -65.5% |
| FY2021 | $2.3B | +69.1% |
| FY2020 | $1.4B | -3.0% |
| FY2019 | $1.4B | -28.3% |
| FY2018 | $2.0B | -5.4% |
| FY2017 | $2.1B | +19.1% |
| FY2016 | $1.7B | -1.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026